Cryopreserving stem cells from young patients at an early stage means preserving their maximum viability.
MIAMI (PRWEB) September 25, 2015
Global Stem Cells Group has announced a new collaboration with Santiago, Chile-based VidaCell Laboratories, Latin America’s oldest and largest cryopreserved umbilical cord cell bank. The alliance is focused on creating new protocols for cryopreservation of cord blood, cord tissue, adipose tissue and dental pulp stem cells, and the culture and expansion of cell colonies.
The GSCG / VidaCel alliance will provide both companies broader access to the newest stem cell technologies for application in new territories. With Global Stem Cells Group’s growing presence in Latin America, the collaboration with VidaCel will eliminate the potential for significant delays in collecting and processing stem cells, which can result in a loss of cell viability.
According to Global Stem Cells Group CEO Benito Novas, the rules of the National Program for Bone Marrow Donation in the U.S. provide the guidelines used by VidaCel for processing cord blood cells within 24 hours.
“VidaCel’s location in Chile guarantees immediate availability of cells,” Novas says.
“Their process of collecting, processing and preserving stem cells is performed under the strictest standards of biosecurity, and designed to better safeguard the material over a lifetime, which makes them a perfect collaborator for Global Stem Cells Group.”
Tissue stem cells, or mesenchymal stem cells, harvested from umbilical cord blood and tissue, can differentiate and generate cells of different tissues, mainly connective or supportive, such as bone, cartilage or muscle. Studies show that they can also participate in the process of tissue regeneration through other mechanisms such as immunosuppression, production factors and cell stimulators present in tissue or a damaged organ. Tissue stem cells also have characteristics that allow them to adapt fairly easily to the action of the immune system of an individual, which is why they are essential for use in allogeneic procedures in which immunologic compatibility is a factor.
Stem cells harvested from adipose tissue can differentiate into bone, cartilage, tendon and muscle, and can strengthen defensive and regenerative function. Adipose stem cells are found in adipose (fat) tissue.
Stem cells harvested from dental pulp can also differentiate into bone, cartilage, tendon and muscle to reinforce their defensive and regenerative function. These cells are found in the teeth.
Over time, the body’s stem cells succumb to environmental insults, a common occurrence in the aging process. Cryopreserving stem cells from young patients at an early stage means preserving their maximum viability.
To learn more, visit the Global Stem Cells Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Established in 2004,VidaCel® is the largest cell blood bank in Latin America, known for its cryopreservation of umbilical cord stem cells, adipose tissue stem cells and dental pulp stem cells. VidaCel follows the rules of the National Program for Bone Marrow Donation’s. U.S. entity, which also provides guidelines concerning Cord Blood Banks.
Located in Santiago, Chile, VidaCel is the first and only public access stem cell bank in Chile, and guarantees immediate availability of cells. VidaCel is committed to the advancement of new technologies and treatments, in conjunction with leading universities. VidaCel is accredited by the Ministry of Health and the Public Health Institute, and all processes are certified by the international quality standard ISO-9001.